TMEM14C
gene geneOn this page
Also known as HSPC194bA421M1.6NET26
Summary
TMEM14C (transmembrane protein 14C, HGNC:20952) is a protein-coding gene on chromosome 6p24.2, encoding Transmembrane protein 14C (Q9P0S9). Required for normal heme biosynthesis.
Predicted to be involved in regulation of heme biosynthetic process. Predicted to act upstream of or within erythrocyte differentiation; mitochondrial transport; and nitrogen compound transport. Located in mitochondrion.
Source: NCBI Gene 51522 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 40 total
- Druggable target: yes
- MANE Select transcript:
NM_016462
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20952 |
| Approved symbol | TMEM14C |
| Name | transmembrane protein 14C |
| Location | 6p24.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HSPC194, bA421M1.6, NET26 |
| Ensembl gene | ENSG00000111843 |
| Ensembl biotype | protein_coding |
| OMIM | 615318 |
| Entrez | 51522 |
Gene structure
Transcript identifiers
Ensembl transcripts: 21 — 18 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000229563, ENST00000466421, ENST00000467415, ENST00000495549, ENST00000541412, ENST00000852872, ENST00000852873, ENST00000852874, ENST00000852875, ENST00000852876, ENST00000852877, ENST00000916629, ENST00000916630, ENST00000916631, ENST00000916632, ENST00000916633, ENST00000916634, ENST00000916635, ENST00000916636, ENST00000916637, ENST00000916638
RefSeq mRNA: 2 — MANE Select: NM_016462
NM_001165258, NM_016462
CCDS: CCDS4514
Canonical transcript exons
ENST00000229563 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001009131 | 10724570 | 10724633 |
| ENSE00001917181 | 10723070 | 10723241 |
| ENSE00003528839 | 10730615 | 10731127 |
| ENSE00003550805 | 10724961 | 10725037 |
| ENSE00003648764 | 10725907 | 10726008 |
| ENSE00003658501 | 10728640 | 10728727 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 99.14.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 180.5653 / max 1265.9112, expressed in 1827 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 65779 | 133.6011 | 1826 |
| 65780 | 45.5208 | 1819 |
| 65778 | 1.4434 | 797 |
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 99.14 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 98.58 | gold quality |
| right adrenal gland | UBERON:0001233 | 98.53 | gold quality |
| left adrenal gland | UBERON:0001234 | 98.43 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 98.41 | gold quality |
| endocervix | UBERON:0000458 | 98.13 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 98.12 | gold quality |
| left uterine tube | UBERON:0001303 | 98.06 | gold quality |
| left coronary artery | UBERON:0001626 | 98.06 | gold quality |
| adrenal gland | UBERON:0002369 | 98.03 | gold quality |
| fallopian tube | UBERON:0003889 | 98.03 | gold quality |
| thoracic aorta | UBERON:0001515 | 98.02 | gold quality |
| prostate gland | UBERON:0002367 | 98.01 | gold quality |
| ascending aorta | UBERON:0001496 | 97.99 | gold quality |
| gall bladder | UBERON:0002110 | 97.98 | gold quality |
| right coronary artery | UBERON:0001625 | 97.96 | gold quality |
| fundus of stomach | UBERON:0001160 | 97.88 | gold quality |
| heart left ventricle | UBERON:0002084 | 97.86 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 97.85 | gold quality |
| heart | UBERON:0000948 | 97.83 | gold quality |
| tibial artery | UBERON:0007610 | 97.83 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 97.83 | gold quality |
| popliteal artery | UBERON:0002250 | 97.82 | gold quality |
| metanephros cortex | UBERON:0010533 | 97.82 | gold quality |
| omental fat pad | UBERON:0010414 | 97.80 | gold quality |
| stromal cell of endometrium | CL:0002255 | 97.79 | gold quality |
| mucosa of stomach | UBERON:0001199 | 97.79 | gold quality |
| endometrium | UBERON:0001295 | 97.79 | gold quality |
| body of uterus | UBERON:0009853 | 97.78 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 97.78 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9388 | yes | 9.33 |
| E-MTAB-3929 | no | 47.38 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
29 targeting TMEM14C, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4753-3P | 99.90 | 71.03 | 3786 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-548AJ-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548F-5P | 99.78 | 71.02 | 3093 |
| HSA-MIR-548G-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-548X-5P | 99.78 | 71.12 | 3085 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-4480 | 99.42 | 66.02 | 735 |
| HSA-MIR-6510-5P | 99.14 | 66.59 | 1081 |
| HSA-MIR-622 | 98.99 | 66.48 | 1050 |
| HSA-MIR-4326 | 98.97 | 67.63 | 962 |
| HSA-MIR-4464 | 98.95 | 67.73 | 820 |
| HSA-MIR-4748 | 98.95 | 67.53 | 810 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-6796-3P | 98.68 | 65.49 | 689 |
| HSA-MIR-6804-5P | 98.39 | 65.77 | 1084 |
| HSA-MIR-4773 | 98.35 | 67.30 | 1710 |
| HSA-MIR-5087 | 98.01 | 69.09 | 965 |
| HSA-MIR-3190-3P | 97.61 | 66.95 | 1406 |
| HSA-MIR-320E | 97.49 | 65.96 | 865 |
| HSA-MIR-6509-5P | 97.39 | 68.27 | 969 |
| HSA-MIR-193A-5P | 95.70 | 65.33 | 613 |
| HSA-MIR-6890-5P | 92.89 | 65.83 | 442 |
Literature-anchored findings (GeneRIF, showing 3)
- Required for functional heme biosynthesis in erythroid cells. (PMID:19656490)
- Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms. (PMID:34172893)
- Coordinated missplicing of TMEM14C and ABCB7 causes ring sideroblast formation in SF3B1-mutant myelodysplastic syndrome. (PMID:34861039)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem14ca | ENSDARG00000110836 |
| danio_rerio | tmem14cb | ENSDARG00000114991 |
| mus_musculus | Tmem14c | ENSMUSG00000021361 |
| rattus_norvegicus | Tmem14cl1 | ENSRNOG00000022144 |
| drosophila_melanogaster | CG5532 | FBGN0034902 |
Paralogs (2): TMEM14A (ENSG00000096092), TMEM14B (ENSG00000137210)
Protein
Protein identifiers
Transmembrane protein 14C — Q9P0S9 (reviewed: Q9P0S9)
All UniProt accessions (1): Q9P0S9
UniProt curated annotations — full annotation on UniProt →
Function. Required for normal heme biosynthesis.
Subcellular location. Mitochondrion membrane.
Similarity. Belongs to the TMEM14 family.
RefSeq proteins (2): NP_001158730, NP_057546* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005349 | TMEM14 | Family |
| IPR044890 | TMEM14_sf | Homologous_superfamily |
Pfam: PF03647
UniProt features (17 total): transmembrane region 4, helix 4, strand 4, sequence variant 4, chain 1
Structure
Experimental structures (PDB)
1 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 2LOS | SOLUTION NMR |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9P0S9-F1 | 61.28 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 179 (showing top):
GOBP_MYELOID_CELL_DIFFERENTIATION, GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN, GOBP_MYELOID_CELL_HOMEOSTASIS, chr6p24, GOBP_ERYTHROCYTE_HOMEOSTASIS, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS, GOBP_MITOCHONDRIAL_TRANSPORT, GOLDRATH_ANTIGEN_RESPONSE, GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS, MCBRYAN_PUBERTAL_BREAST_4_5WK_DN, GOBP_TETRAPYRROLE_METABOLIC_PROCESS, GOBP_PIGMENT_METABOLIC_PROCESS, GOCC_MITOCHONDRIAL_ENVELOPE, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP
GO Biological Process (4): heme biosynthetic process (GO:0006783), mitochondrial transport (GO:0006839), erythrocyte differentiation (GO:0030218), transmembrane transport (GO:0055085)
GO Molecular Function (2): transmembrane transporter activity (GO:0022857), protein binding (GO:0005515)
GO Cellular Component (4): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| porphyrin-containing compound biosynthetic process | 1 |
| heme metabolic process | 1 |
| pigment biosynthetic process | 1 |
| intracellular transport | 1 |
| myeloid cell differentiation | 1 |
| erythrocyte homeostasis | 1 |
| transport | 1 |
| cellular process | 1 |
| transporter activity | 1 |
| transmembrane transport | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
916 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM14C | ABCB7 | O75027 | 806 |
| TMEM14C | ABCB10 | Q9NRK6 | 709 |
| TMEM14C | FECH | P22830 | 698 |
| TMEM14C | SLC25A39 | Q9BZJ4 | 636 |
| TMEM14C | ISCA1 | Q9BUE6 | 583 |
| TMEM14C | ENOSF1 | Q7L5Y1 | 570 |
| TMEM14C | IBA57 | Q5T440 | 568 |
| TMEM14C | SLC25A37 | Q9NYZ2 | 554 |
| TMEM14C | PPOX | P50336 | 540 |
| TMEM14C | SLC25A38 | Q96DW6 | 500 |
| TMEM14C | ABCB6 | Q9NP58 | 498 |
| TMEM14C | CPOX | P36551 | 490 |
| TMEM14C | COASY | Q13057 | 477 |
| TMEM14C | ALAS2 | P22557 | 476 |
| TMEM14C | UQCC1 | Q9NVA1 | 471 |
IntAct
134 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM14C | KASH5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | CYB5R3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | PDZK1IP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | NCAPH2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | ELOVL7 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | TMX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | VSIR | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | SLC10A6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | HSD17B13 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | GORAB | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | EBP | psi-mi:“MI:0915”(physical association) | 0.560 |
| STX1A | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM79 | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| MFF | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCL2L13 | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| SDC3 | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| CREB3L1 | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| BIK | TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM14C | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (66): CCDC155 (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Proximity Label-MS), TMEM14C (Co-fractionation), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid), TMEM14C (Two-hybrid)
ESM2 similar proteins: A4DA06, A8MWL7, A9UY97, O14238, O64847, P0CS25, P25338, P38166, P46964, P47131, P63030, P63031, P93829, Q0P436, Q12116, Q18319, Q22252, Q28GF5, Q295N5, Q3SZ36, Q3TUD9, Q3ZCG2, Q3ZCI1, Q4V7N7, Q55GU4, Q5F410, Q5R751, Q6C741, Q6CMQ1, Q6DGF8, Q74Z81, Q750M8, Q75JB5, Q7KSC4, Q8INQ7, Q8IQ56, Q8NNK3, Q924P2, Q96B42, Q9C6T7
Diamond homologs: A8MWL7, O64847, P47131, P56982, P56983, P56984, Q0P436, Q3ZCI1, Q5R751, Q6UXP3, Q75JB5, Q924P2, Q9C6T7, Q9CQN6, Q9LJU6, Q9NUH8, Q9P0S9, Q9W1K0, Q9Y6G1, Q8LPG1, Q94A32, Q9P7G3, Q93V66, Q9ZVH7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
40 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 18 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
750 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:10724632:GT:G | donor_gain | 1.0000 |
| 6:10724960:GA:G | acceptor_gain | 1.0000 |
| 6:10725034:GCAG:G | donor_gain | 1.0000 |
| 6:10725990:A:T | donor_gain | 1.0000 |
| 6:10723237:GACCG:G | donor_gain | 0.9900 |
| 6:10723248:G:GG | donor_gain | 0.9900 |
| 6:10723256:G:GT | donor_gain | 0.9900 |
| 6:10724634:G:GG | donor_gain | 0.9900 |
| 6:10724955:TTTCA:T | acceptor_loss | 0.9900 |
| 6:10724956:TTCA:T | acceptor_loss | 0.9900 |
| 6:10724957:TCAGA:T | acceptor_loss | 0.9900 |
| 6:10724958:CAG:C | acceptor_gain | 0.9900 |
| 6:10724959:A:AG | acceptor_gain | 0.9900 |
| 6:10724959:AGA:A | acceptor_gain | 0.9900 |
| 6:10724959:AGAGT:A | acceptor_gain | 0.9900 |
| 6:10724960:G:C | acceptor_gain | 0.9900 |
| 6:10724960:G:GA | acceptor_loss | 0.9900 |
| 6:10724960:G:GG | acceptor_gain | 0.9900 |
| 6:10724960:GAGT:G | acceptor_gain | 0.9900 |
| 6:10724960:GAGTG:G | acceptor_gain | 0.9900 |
| 6:10725033:AGCAG:A | donor_loss | 0.9900 |
| 6:10725035:CAGG:C | donor_loss | 0.9900 |
| 6:10725036:AG:A | donor_loss | 0.9900 |
| 6:10725037:GGTAG:G | donor_loss | 0.9900 |
| 6:10725038:GT:G | donor_loss | 0.9900 |
| 6:10725039:T:G | donor_loss | 0.9900 |
| 6:10723023:G:GT | donor_gain | 0.9800 |
| 6:10723256:G:T | donor_gain | 0.9800 |
| 6:10728709:GTT:G | donor_gain | 0.9800 |
| 6:10728710:TTT:T | donor_gain | 0.9800 |
AlphaMissense
717 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 6:10725925:C:A | A39D | 0.996 |
| 6:10725943:G:A | G45D | 0.996 |
| 6:10728669:G:A | G77R | 0.996 |
| 6:10728669:G:C | G77R | 0.996 |
| 6:10725931:G:A | G41E | 0.995 |
| 6:10725945:A:C | S46R | 0.995 |
| 6:10725947:T:A | S46R | 0.995 |
| 6:10725947:T:G | S46R | 0.995 |
| 6:10728668:G:A | M76I | 0.995 |
| 6:10728668:G:C | M76I | 0.995 |
| 6:10728668:G:T | M76I | 0.995 |
| 6:10728676:G:T | R79M | 0.995 |
| 6:10725930:G:A | G41R | 0.994 |
| 6:10725930:G:C | G41R | 0.994 |
| 6:10725930:G:T | G41W | 0.994 |
| 6:10728670:G:A | G77E | 0.994 |
| 6:10728709:G:A | G90D | 0.994 |
| 6:10725002:T:A | V21D | 0.993 |
| 6:10725011:G:A | G24D | 0.993 |
| 6:10725023:G:A | G28D | 0.993 |
| 6:10725928:C:A | A40E | 0.993 |
| 6:10725942:G:C | G45R | 0.993 |
| 6:10728703:C:A | P88H | 0.993 |
| 6:10728677:G:C | R79S | 0.992 |
| 6:10728677:G:T | R79S | 0.992 |
| 6:10728720:G:C | G94R | 0.992 |
| 6:10724993:C:A | A18E | 0.991 |
| 6:10725005:C:A | A22D | 0.991 |
| 6:10725013:G:A | G25R | 0.991 |
| 6:10725013:G:C | G25R | 0.991 |
dbSNP variants (sampled 300 via entrez): RS1000075062 (6:10730890 G>A,C), RS1000462406 (6:10722636 C>A,T), RS1000743943 (6:10723195 C>G,T), RS1000760717 (6:10721305 C>A,T), RS1000811826 (6:10722412 CAG>C), RS1001112884 (6:10730518 C>A,G,T), RS1001299785 (6:10722874 T>G), RS1001335202 (6:10724906 T>C), RS1001471800 (6:10727330 C>T), RS1001644829 (6:10722691 G>A), RS1001652651 (6:10721143 A>G), RS1002155850 (6:10724836 C>A,G,T), RS1002271909 (6:10729757 G>A), RS1002605615 (6:10728426 G>A), RS1003124948 (6:10724564 C>A,G,T)
Disease associations
OMIM: gene MIM:615318 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004862_63 | Itch intensity from mosquito bite adjusted by bite size | 3.000000e-07 |
| GCST009172_2 | Response to (pegylated) interferon in HBeAg-negative hepatitis B | 3.000000e-06 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008377 | mosquito bite reaction itch intensity measurement |
| EFO:0008378 | mosquito bite reaction size measurement |
| EFO:0007859 | response to interferon |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL6067360 (SINGLE PROTEIN)
PharmGKB: 1 entry (VIP=true, CPIC=false)
ChEMBL bioactivities
2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 6.95 | Kd | 112.7 | nM | CHEMBL5653589 |
| 6.95 | ED50 | 112.7 | nM | CHEMBL5653589 |
PubChem BioAssay actives
1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.
| Compound | Assay | Type | Value | Unit |
|---|---|---|---|---|
| 4-methyl-3-[(2-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide | 2149608: Binding affinity to human TMEM14C incubated for 45 mins by Kinobead based pull down assay | kd | 0.1127 | uM |
CTD chemical–gene interactions
34 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression, decreases expression, affects cotreatment | 2 |
| Air Pollutants | decreases expression, increases abundance | 2 |
| ginger extract | affects cotreatment, affects expression, increases abundance | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, affects expression, increases abundance | 1 |
| arsenite | affects binding, increases reaction | 1 |
| perfluorooctanoic acid | increases expression | 1 |
| CD 437 | decreases expression | 1 |
| chloropicrin | affects expression | 1 |
| perfluoro-n-nonanoic acid | increases expression | 1 |
| 3-(4’-hydroxy-3’-adamantylbiphenyl-4-yl)acrylic acid | decreases expression | 1 |
| ICG 001 | increases expression | 1 |
| gardiquimod | decreases expression, decreases reaction | 1 |
| picoxystrobin | increases expression | 1 |
| Arsenic | increases abundance, increases expression, decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Cisplatin | increases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Oils, Volatile | affects cotreatment, affects expression, increases abundance | 1 |
| Rotenone | increases expression | 1 |
| Smoke | decreases expression, increases abundance | 1 |
| Valproic Acid | affects expression | 1 |
| Sodium Selenite | increases expression | 1 |
| Cadmium Chloride | increases expression, increases abundance | 1 |
ChEMBL screening assays
1 unique, capped per target: 1 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL5652650 | Binding | Binding affinity to human TMEM14C incubated for 45 mins by Kinobead based pull down assay | NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.